跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
H. Lundbeck A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 12, 2024
Approval ID
09a85d2b193ade05
Company
H. Lundbeck A/S
Type
Standard
Approval Details
Approval Id
09a85d2b193ade05
Drug Cima Aemps Name
BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
113891028IP
Holder Company Name
H. Lundbeck A/S
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/h-lundbeck-a-s
Authorization Date
2024-07-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
H. Lundbeck A/S
Company Detail Path
/organization/h-lundbeck-a-s
Company Information
Pharmaceutical Company Name
H. Lundbeck A/S
Name En
H. Lundbeck A/S
Country Name
Denmark
City Name
valby,hovedstaden,country_dk
Address
Ottiliavej 9
Website
https://www.lundbeck.com
Active Ingredients
VORTIOXETINA HIDROBROMURO
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 12, 2024
Approval ID
09a85d2b193ade05
Type
Standard
Back to CIMA-AEMPS Approvals
